<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05790915</url>
  </required_header>
  <id_info>
    <org_study_id>HSD 2023 1</org_study_id>
    <nct_id>NCT05790915</nct_id>
  </id_info>
  <brief_title>Impact of Interventions on Admissional SOFA Score on Clinical Outcomes of Critically Ill Patients</brief_title>
  <official_title>Impact of Interventions on Admissional SOFA Score on Clinical Outcomes of Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sao Domingos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Sao Domingos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Introduction: The SOFA score (Sequential Organ Function Assessment) and its derived measures,&#xD;
      such as the Delta SOFA, are used worldwide to determine the severity and prognosis of&#xD;
      critically ill patients.&#xD;
&#xD;
      Objectives: The primary objective of this study was to assess the impact of standardized&#xD;
      interventions on the six organ dysfunctions of SOFA score on outcomes of critically ill&#xD;
      patients through the 48-hour delta SOFA score and 28 days mortality. The secondary outcome&#xD;
      measures comprised the evaluation of standardized interventions on ICU and hospital length of&#xD;
      stay ; duration of mechanical ventilation and time using vasoactive drugs. Uni and&#xD;
      multivariate statistical analysis will be used to determine organ failures associated to&#xD;
      outcome.&#xD;
&#xD;
      Methods: Interventional prospective cohort study involving patients admitted to three ICUs of&#xD;
      a tertiary hospital from April 01, 2023 to March 31, 2024. Whenever an admission SOFA score â‰¥&#xD;
      2 is identified a standardized protocol of interventions is implemented in the therapeutic&#xD;
      plan of the patient (Table 1). A new SOFA score after 48 hours will determine the tendency of&#xD;
      the SOFA Score (Delta SOFA) and the result will be correlated with the 28-day mortality&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Table 1. SOFA standardized protocol&#xD;
&#xD;
        1. Respiratory Protective mechanical ventilation; mechanical power &lt; 16, NIV Prevention of&#xD;
           PSILI: ROX and HACOR index&#xD;
&#xD;
        2. Hemodynamic SOSD protocol; Pressoric target; Lactate clearance&#xD;
&#xD;
        3. Neurologic Image; EEG; Sedation goals&#xD;
&#xD;
        4. Hematologic Basic disease approach; drugs; DDAVP use&#xD;
&#xD;
        5. Renal Avoid nephrotoxicity; Avoide hypotension&#xD;
&#xD;
        6. Hepatic Avoid hepatotoxic drugs; basic disease approach.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2023</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">March 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Impact of standardized interventions in respiratory dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hours</time_frame>
    <description>Lung protective ventilation: Tidal volume = 6 ml/kg; Plateau pressure &lt; 28 mmHg; driving pressue &lt; 16 cm H2O; Mechanical power &lt; 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index &gt; 4.8 and HACOR &lt; 5.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of standardized interventions in hemodinamic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hour</time_frame>
    <description>SOSD (salvage, optimization, stabilization and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level &lt; 19 mg/dL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of standardized interventions in neurologic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hour</time_frame>
    <description>Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of standardized interventions in hematologic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hour</time_frame>
    <description>Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of standardized interventions iin renal dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hour</time_frame>
    <description>Avoid nephotoxic drugs; Mantain mean arterial blood pressure &gt; 65 mmHg</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Impact of standardized interventions in hepatic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>48 hour</time_frame>
    <description>Avoid hepatotoxic drugs;basic disease approach</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions in respiratory dysfunction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>Lung protective ventilation: Tidal volume 6 ml/kg; Pateau pressure &lt; 28 mmHg; driving pressue &lt; 16 cm H2O; Mechanical power &lt; 16 Joules/min; Prevention of self-inflicted lung injury (P-SILI): ROX index &gt; 4.8 and HACOR &lt; 5.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions in hemodinamic dysfuction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>SOSD (salvage, optimization, stabilixation and de-escalation ) protocol; mean arterial pressoric taget of at least 65 mm Hg, Lactate serum level &lt; 19 mg/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions in neurologic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>Image: cranial CT; Electroencephalografic monitoring and RASS Score between -1 and +1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions in hematologic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>Basic disease approach; avoid drugs that interfere with coagulation; Platelet transfusion in case of hemohhage; DDAVP when indicated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions iin renal dysfunction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>Avoid nephotoxic drugs; Mantain mean arterial blood pressure &gt; 65 mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of standardized interventions in hepatic dysfunction on 48-hour delta SOFA</measure>
    <time_frame>28 days</time_frame>
    <description>Avaoid hepatotoxic drugs;basic disease approach</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Critically Ill Patients</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients with SOFA score &lt; 2 at admission. No intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients with SOFA score equal to or &gt; 2 on admission and who improved after 48 hours of treatment.&#xD;
Intervention focused on identified organ dysfunction(s)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>Patients with SOFA score equal to or &gt; 2 on admission and who did not improve after 48 hours of treatment.&#xD;
Intervention focused on identified organ dysfunction(s)</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Standardized interventions</intervention_name>
    <description>Standardized interventions according organ dysfunction</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to a medical ICU, a Surgical ICU and a High complexity surgical and&#xD;
        trauma ICU in the period from April 01, 2023 to March 31, 2024 and lenght of stay of at&#xD;
        least 3 days.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged above 18 years,&#xD;
&#xD;
          -  Lenght of ICU stay of at least 3 days.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant patients&#xD;
&#xD;
          -  End-of-life&#xD;
&#xD;
          -  Patients readmitted to the ICU in the same hospitalization&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JOSE R AZEVEDO, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Sao Domingos</affiliation>
  </overall_official>
  <overall_official>
    <last_name>BARBARA L RIBEIRO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Sao Domingos</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JOSE R DE AZEVEDO, MD, PhD</last_name>
    <phone>98991375595</phone>
    <email>jrazevedo47@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>CRISTIANA Q VASCONCELOS, MD</last_name>
    <phone>+55 98 32168110</phone>
    <email>cristianasqv@gmail.com</email>
  </overall_contact_backup>
  <reference>
    <citation>Anami EH, Grion CM, Cardoso LT, Kauss IA, Thomazini MC, Zampa HB, Bonametti AM, Matsuo T. Serial evaluation of SOFA score in a Brazilian teaching hospital. Intensive Crit Care Nurs. 2010 Apr;26(2):75-82. doi: 10.1016/j.iccn.2009.10.005. Epub 2009 Dec 29.</citation>
    <PMID>20036543</PMID>
  </reference>
  <results_reference>
    <citation>Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest. 1992 Jun;101(6):1481-3. doi: 10.1378/chest.101.6.1481. No abstract available.</citation>
    <PMID>1600757</PMID>
  </results_reference>
  <results_reference>
    <citation>Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med. 1999 Jul;25(7):686-96. doi: 10.1007/s001340050931.</citation>
    <PMID>10470572</PMID>
  </results_reference>
  <results_reference>
    <citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996 Jul;22(7):707-10. doi: 10.1007/BF01709751. No abstract available.</citation>
    <PMID>8844239</PMID>
  </results_reference>
  <results_reference>
    <citation>Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009 May;37(5):1649-54. doi: 10.1097/CCM.0b013e31819def97.</citation>
    <PMID>19325482</PMID>
  </results_reference>
  <results_reference>
    <citation>de Azevedo JR, Torres OJ, Beraldi RA, Ribas CA, Malafaia O. Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs Delta Sequential Organ Failure Assessment. J Crit Care. 2015 Feb;30(1):219.e9-12. doi: 10.1016/j.jcrc.2014.08.018. Epub 2014 Sep 10.</citation>
    <PMID>25241933</PMID>
  </results_reference>
  <results_reference>
    <citation>Soo A, Zuege DJ, Fick GH, Niven DJ, Berthiaume LR, Stelfox HT, Doig CJ. Describing organ dysfunction in the intensive care unit: a cohort study of 20,000 patients. Crit Care. 2019 May 23;23(1):186. doi: 10.1186/s13054-019-2459-9.</citation>
    <PMID>31122276</PMID>
  </results_reference>
  <results_reference>
    <citation>de Grooth HJ, Geenen IL, Girbes AR, Vincent JL, Parienti JJ, Oudemans-van Straaten HM. SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis. Crit Care. 2017 Feb 24;21(1):38. doi: 10.1186/s13054-017-1609-1.</citation>
    <PMID>28231816</PMID>
  </results_reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>February 21, 2023</study_first_submitted>
  <study_first_submitted_qc>March 16, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2023</study_first_posted>
  <last_update_submitted>April 16, 2023</last_update_submitted>
  <last_update_submitted_qc>April 16, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sao Domingos</investigator_affiliation>
    <investigator_full_name>JosÃ© Raimundo Araujo de Azevedo</investigator_full_name>
    <investigator_title>ICU Assistent Physician</investigator_title>
  </responsible_party>
  <keyword>SOFA Score</keyword>
  <keyword>Delta SOFA</keyword>
  <keyword>Critically ill patients</keyword>
  <keyword>Interventions</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

